ARTICLE | Clinical News
Compugen preclinical data
November 2, 2009 8:00 AM UTC
In a mouse model of inflammation, CGEN-25007 reduced tumor necrosis factor (TNF) alpha by >50% vs. control in serum obtained 90 minutes post-administration (p=0.001). In serum obtained 6 hours post-a...